211 related articles for article (PubMed ID: 22373101)
1. Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A.
Grover A; Agrawal V; Shandilya A; Bisaria VS; Sundar D
BMC Bioinformatics; 2011; 12 Suppl 13(Suppl 13):S22. PubMed ID: 22373101
[TBL] [Abstract][Full Text] [Related]
2. Effects of Acyclovir, Foscarnet, and Ribonucleotides on Herpes Simplex Virus-1 DNA Polymerase: Mechanistic Insights and a Novel Mechanism for Preventing Stable Incorporation of Ribonucleotides into DNA.
Vashishtha AK; Kuchta RD
Biochemistry; 2016 Feb; 55(7):1168-77. PubMed ID: 26836009
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus resistance to antiviral drugs.
Morfin F; Thouvenot D
J Clin Virol; 2003 Jan; 26(1):29-37. PubMed ID: 12589832
[TBL] [Abstract][Full Text] [Related]
4. Identification of a small molecule that inhibits herpes simplex virus DNA Polymerase subunit interactions and viral replication.
Pilger BD; Cui C; Coen DM
Chem Biol; 2004 May; 11(5):647-54. PubMed ID: 15157875
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the herpes simplex virus 1 DNA polymerase.
Liu S; Knafels JD; Chang JS; Waszak GA; Baldwin ET; Deibel MR; Thomsen DR; Homa FL; Wells PA; Tory MC; Poorman RA; Gao H; Qiu X; Seddon AP
J Biol Chem; 2006 Jun; 281(26):18193-200. PubMed ID: 16638752
[TBL] [Abstract][Full Text] [Related]
6. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the interactions between the subunits of herpesvirus DNA polymerases as a novel antiviral strategy.
Loregian A; Palù G
Clin Microbiol Infect; 2005 Jun; 11(6):437-46. PubMed ID: 15882193
[TBL] [Abstract][Full Text] [Related]
8. (+-)-(1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)-cyclobutyl] guanine [(+-)-BHCG or SQ 33,054]: a potent and selective inhibitor of herpesviruses.
Field AK; Tuomari AV; McGeever-Rubin B; Terry BJ; Mazina KE; Haffey ML; Hagen ME; Clark JM; Braitman A; Slusarchyk WA
Antiviral Res; 1990 Jan; 13(1):41-52. PubMed ID: 2159261
[TBL] [Abstract][Full Text] [Related]
9. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
Andrei G; Gillemot S; Topalis D; Snoeck R
J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells.
Stenberg K; Larsson A; Datema R
J Biol Chem; 1986 Feb; 261(5):2134-9. PubMed ID: 2418021
[TBL] [Abstract][Full Text] [Related]
11. Hinge Region in DNA Packaging Terminase pUL15 of Herpes Simplex Virus: A Potential Allosteric Target for Antiviral Drugs.
Thaljeh LF; Rothschild JA; Naderi M; Coghill LM; Brown JM; Brylinski M
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31614784
[TBL] [Abstract][Full Text] [Related]
12. On the complex nature of the antiviral activity of coumermycin A1: its interference with the replication of herpes simplex virus type 1.
Palù G; Meloni GA; von Berger J; Masotti L
Antiviral Res; 1986 Jan; 6(1):19-32. PubMed ID: 3008643
[TBL] [Abstract][Full Text] [Related]
13. Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases.
Balzarini J; Ford A; Maguire NM; John J; Das K; Arnold E; Dehaen W; Maguire A
Future Med Chem; 2019 Jan; 11(2):137-154. PubMed ID: 30648904
[TBL] [Abstract][Full Text] [Related]
14. Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections.
Biswas S; Sukla S; Field HJ
Future Med Chem; 2014 Jan; 6(1):45-55. PubMed ID: 24358947
[TBL] [Abstract][Full Text] [Related]
15. Antiviral Active Compounds Derived from Natural Sources against Herpes Simplex Viruses.
van de Sand L; Bormann M; Schmitz Y; Heilingloh CS; Witzke O; Krawczyk A
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372592
[TBL] [Abstract][Full Text] [Related]
16. The structure and function of the HSV DNA replication proteins: defining novel antiviral targets.
Matthews JT; Terry BJ; Field AK
Antiviral Res; 1993 Feb; 20(2):89-114. PubMed ID: 8384825
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of herpes simplex virus DNA polymerase by helical peptides corresponding to the subunit interface.
Digard P; Williams KP; Hensley P; Brooks IS; Dahl CE; Coen DM
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1456-60. PubMed ID: 7878000
[TBL] [Abstract][Full Text] [Related]
18. Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties.
Hassan STS; Šudomová M; Berchová-Bímová K; Šmejkal K; Echeverría J
Molecules; 2019 Aug; 24(16):. PubMed ID: 31405197
[TBL] [Abstract][Full Text] [Related]
19. Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistance.
Griffiths A
Drug Resist Updat; 2011 Dec; 14(6):251-9. PubMed ID: 21940196
[TBL] [Abstract][Full Text] [Related]
20. Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study.
Cai Z; Zhang G; Tang B; Liu Y; Fu X; Zhang X
Cell Biochem Biophys; 2015 Jul; 72(3):727-39. PubMed ID: 25627548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
